The European Medicines Agency (EMA) has launched a network of databases containing sources of real-world data (RWD) approved by the EMA for use as evidence in clinical trials.

The Coordination Centre for the Data Analysis and Real-World Interrogation Network (DARWIN EU) will give researchers and regulators access to curated sources of information on diseases, patient populations and more, as well as guidance for using the data in drug trials.

DARWIN-EU also will use the data in the network to conduct observational studies requested by EU regulators. Eventually, it will take on other observational study requests.